Verwendung von Daptomycin

European patent · EP1674107 · Deleted

Register entry

Publication number
EP1674107
Application number
EP06006697
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 24, 1999
Published
Jun 28, 2006
Granted
Aug 24, 2016
Deleted
Sep 23, 2019
Reason
Maximum term reached
IPC classes
A61K 38/12 (2006.01)
A61P 31/04 (2006.01)
Priority
US 101828 P 25.09.1998
US 125750 P 24.03.1999
Divided from
EP99949913
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 30, 2019

    Maximum term reached

    Published in Swissreg on 30.09.2019

  2. Dec 15, 2016

    Address changed

    Owner
    Cubist Pharmaceuticals LLC, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA → Cubist Pharmaceuticals LLC, Weystrasse 20, 6000 Luzern 6

    Published in Swissreg on 15.12.2016

  3. Nov 3, 2016

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 03.11.2016

  4. Aug 24, 2016

    Granted

    Published in Swissreg on 24.08.2016

Parties

Holder

Cubist Pharmaceuticals LLC

Weystrasse 20, 6000 Luzern 6

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

Oleson, Frederick B. Jr.

Concord, MA01742, US

Tally, Francis P.

Lincoln, MA 01733, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.